Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Remedent's share price for the quarter that ended in Dec. 2020 was $0.15. Remedent's Shares Outstanding (EOP) for the quarter that ended in Dec. 2020 was 20.00 Mil. Therefore, Remedent's market cap for the quarter that ended in Dec. 2020 was $3.00 Mil.
Remedent's quarterly market cap
declined
from Jun. 2020 ($3.60 Mil) to Sep. 2020 ($2.80 Mil) but then
increased
from Sep. 2020 ($2.80 Mil) to Dec. 2020 ($3.00 Mil).
Remedent's annual market cap
declined
from Mar. 2018 ($5.00 Mil) to Mar. 2019 ($4.00 Mil) and
declined
from Mar. 2019 ($4.00 Mil) to Mar. 2020 ($3.60 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Remedent's Enterprise Value for Today is $0.01 Mil.
Remedent (OTCPK:REMI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Remedent Market Cap Related Terms
Remedent Market Cap Historical Data
* Premium members only.
The historical data trend for Remedent's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Remedent's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Remedent Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Remedent's Market Cap distribution charts can be found below:
* The bar in red indicates where Remedent's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Remedent's Market Cap for the fiscal year that ended in Mar. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Remedent (REMI) has a Market Cap of $0.01 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Remedent and its competitors.
Is Remedent's Market Cap too high?
Remedent's current Market Cap is $0.01 Mil. The Medical Devices & Instruments industry median Market Cap is 118.46. Remedent's value of $0.01 Mil is 100% below this industry median. Overall, Remedent has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Remedent's Market Cap compare to SECI and RSCF?
Remedent's Market Cap of $0.01 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 118.46. Remedent's value of $0.01 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.46, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Remedent's current Market Cap of $0.01 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Remedent and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Remedent's current Market Cap is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remedent stock overvalued right now?
Remedent (REMI) has a current Market Cap of $0.01 Mil. The current Market Cap is $0.01 Mil and 100% below the Medical Devices & Instruments industry median of 118.46. Remedent's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Remedent (REMI), the current Market Cap is $0.01 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States.
12GF Score
Get the complete analysis for REMI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REMI has been successfully added to your 
